TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism

Nature Genetics

Volumn 48, Issue 1, 2015, Pages 36-43

  Harley, Margaret E ^a   Murina, Olga ^a   Leitch, Andrea ^a   Higgs, Martin R ^b   Bicknell, Louise S ^a,p   Yigit, Gökhan ^c,d   Blackford, Andrew N ^e   Zlatanou, Anastasia ^b   Mackenzie, Karen J ^a   Reddy, Kaalak ^a   Halachev, Mihail ^a   McGlasson, Sarah ^a   Reijns, Martin A M ^a   Fluteau, Adeline ^a   Martin, Carol Anne ^a   Sabbioneda, Simone ^f   Elcioglu, Nursel H ^g   Altmüller, Janine ^c,h   Thiele, Holger ^h   Greenhalgh, Lynn ⁱ   Chessa, Luciana ^j   Maghnie, Mohamad ^k   Salim, Mahmoud ^g   Bober, Michael B ^l   Nürnberg, Peter ^d,h   Jackson, Stephen P ^e,m,n   Hurles, Matthew E ⁿ   Wollnik, Bernd ^c,d,o   Stewart, Grant S ^b   Jackson, Andrew P ^a   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f CNR   (Italy)

^g MARMARA UNIVERSITY   (Turkey)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^j SAPIENZA UNIVERSITY OF ROME   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

^l NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^o UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^p UNIVERSITY OF OTAGO   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; PROTEIN; PROTEIN RPA2; PROTEIN TRAIP; UNCLASSIFIED DRUG; H2AFX PROTEIN, HUMAN; HISTONE; REPLICATION FACTOR A; RPA2 PROTEIN, HUMAN; TRAIP PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DWARFISM; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE REPLICATION; HUMAN; HUMAN CELL; MALE; MICROCEPHALIC PRIMORDIAL DWARFISM; MICROCEPHALY; PATHOGENESIS; PHENOTYPE; PRESCHOOL CHILD; PRIMORDIAL DWARFISM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SEQUENCE ANALYSIS; TRAIP GENE; ULTRAVIOLET IRRADIATION; WHOLE EXOME SEQUENCING; AMINO ACID SEQUENCE; FACIES; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PHOSPHORYLATION; RADIATION RESPONSE; ULTRAVIOLET RADIATION;

AMINO ACID SEQUENCE; CELL PROLIFERATION; CHILD, PRESCHOOL; DNA DAMAGE; DWARFISM; FACIES; HISTONES; HUMANS; MICROCEPHALY; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; REPLICATION PROTEIN A; S PHASE; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UBIQUITIN-PROTEIN LIGASES; ULTRAVIOLET RAYS;

EID: 84947997687     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3451     Document Type: Article

References (61)

1. Ciccia, A., & Elledge, S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204 (2010).
2. Jackson, S.P., & Durocher, D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 49, 795-807 (2013).
3. Slatter, M.A., & Gennery, A.R. Primary immunodeficiencies associated with DNA-repair disorders. Expert Rev. Mol. Med. 12, e9 (2010).
4. Woods, C.G. DNA repair disorders. Arch. Dis. Child. 78, 178-184 (1998).
5. German, J. Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients. Am. J. Hum. Genet. 21, 196-227 (1969).
6. Murray, J.E., et al. Extreme growth failure is a common presentation of ligase IV deficiency. Hum. Mutat. 35, 76-85 (2014).
7. O'Driscoll, M., Ruiz-Perez, V.L., Woods, C.G., Jeggo, P.A., & Goodship, J.A. A splicing mutation affecting expression of ataxia-Telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33, 497-501 (2003).
8. Ogi, T., et al. Identification of the first ATRIP-Deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel syndrome. PLoS Genet. 8, e1002945 (2012).
9. Jackson, S.P., & Bartek, J. The DNA-Damage response in human biology and disease. Nature 461, 1071-1078 (2009).
10. Klingseisen, A., & Jackson, A.P. Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev. 25, 2011-2024 (2011).
11. Majewski, F., & Goecke, T. Studies of microcephalic primordial dwarfism I: approach to a delineation of the Seckel syndrome. Am. J. Med. Genet. 12, 7-21 (1982).
12. Seckel, H.P.G. Bird-Headed Dwarfs (S. Karger, 1960).
13. Majewski, F., Ranke, M., & Schinzel, A. Studies of microcephalic primordial dwarfism II: the osteodysplastic type II of primordial dwarfism. Am. J. Med. Genet. 12, 23-35 (1982).
14. Majewski, F., Stoeckenius, M., & Kemperdick, H. Studies of microcephalic primordial dwarfism III: an intrauterine dwarf with platyspondyly and anomalies of pelvis and clavicles-osteodysplastic primordial dwarfism type III. Am. J. Med. Genet. 12, 37-42 (1982).
15. Bongers, E.M., et al. Meier-Gorlin syndrome: report of eight additional cases and review. Am. J. Med. Genet. 102, 115-124 (2001).
16. Gorlin, R.J., Cervenka, J., Moller, K., Horrobin, M., & Witkop, C.J. Jr. Malformation syndromes. A selected miscellany. Birth Defects Orig. Artic. Ser. 11, 39-50 (1975).
17. Rauch, A., et al. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science 319, 816-819 (2008).
18. Griffith, E., et al. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat. Genet. 40, 232-236 (2008).
19. Qvist, P., et al. CtIP mutations cause Seckel and Jawad syndromes. PLoS Genet. 7, e1002310 (2011).
20. Leutenegger, A.L., et al. Using genomic inbreeding coefficient estimates for homozygosity mapping of rare recessive traits: application to Taybi-Linder syndrome. Am. J. Hum. Genet. 79, 62-66 (2006).
21. Borden, K.L., & Freemont, P.S. The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6, 395-401 (1996).
22. Silengo, M., Del Monaco, A., Linari, A., & Lala, R. Low birth-weight, microcephalic malformation syndrome in a 46, XX girl and her 46, XY sister with agonadism: third report of the Kennerknecht syndrome or autosomal recessive Seckel-like syndrome with previously undescribed genital anomalies. Am. J. Med. Genet. 101, 275-278 (2001).
23. Besse, A., Campos, A.D., Webster, W.K., & Darnay, B.G. TRAF-interacting protein (TRIP) is a RING-Dependent ubiquitin ligase. Biochem. Biophys. Res. Commun. 359, 660-664 (2007).
24. Lee, S.Y., Lee, S.Y., & Choi, Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)-and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation. J. Exp. Med. 185, 1275-1285 (1997).
25. Zhang, M., et al. TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J. Exp. Med. 209, 1703-1711 (2012).
26. Park, E.S., et al. Early embryonic lethality caused by targeted disruption of the TRAF-interacting protein (TRIP) gene. Biochem. Biophys. Res. Commun. 363, 971-977 (2007).
27. Räschle, M., et al. DNA repair. Proteomics reveals dynamic assembly of repair complexes during bypass of DNA cross-links. Science 348, 1253671 (2015).
28. Han, C., et al. Cdt2-mediated XPG degradation promotes gap-filling DNA synthesis in nucleotide excision repair. Cell Cycle 14, 1103-1115 (2015).
29. Almeida, S., Ryser, S., Obarzanek-Fojt, M., Hohl, D., & Huber, M. The TRAF-interacting protein (TRIP) is a regulator of keratinocyte proliferation. J. Invest. Dermatol. 131, 349-357 (2011).
30. Branzei, D., & Foiani, M. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell Biol. 11, 208-219 (2010).
31. Wallace, H.A., et al. TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase-?. Development 141, 1332-1341 (2014).
32. Bienko, M., et al. Regulation of translesion synthesis DNA polymerase-? by monoubiquitination. Mol. Cell 37, 396-407 (2010).
33. Lehmann, A.R., McGibbon, D., & Stefanini, M. Xeroderma pigmentosum. Orphanet J. Rare Dis. 6, 70 (2011).
34. Masutani, C., et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399, 700-704 (1999).
35. Johnson, R.E., Kondratick, C.M., Prakash, S., & Prakash, L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285, 263-265 (1999).
36. Despras, E., Daboussi, F., Hyrien, O., Marheineke, K., & Kannouche, P.L. ATR/Chk1 pathway is essential for resumption of DNA synthesis and cell survival in UV-irradiated XP variant cells. Hum. Mol. Genet. 19, 1690-1701 (2010).
37. Shi, W., et al. The role of RPA2 phosphorylation in homologous recombination in response to replication arrest. Carcinogenesis 31, 994-1002 (2010).
38. Nakada, S., Chen, G.I., Gingras, A.C., & Durocher, D. PP4 is a αH2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep. 9, 1019-1026 (2008).
39. Chowdhury, D., et al. A PP4-phosphatase complex dephosphorylates αH2AX generated during DNA replication. Mol. Cell 31, 33-46 (2008).
40. Chowdhury, D., et al. α-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol. Cell 20, 801-809 (2005).
41. Feng, J., et al. Protein phosphatase 2A-Dependent dephosphorylation of replication protein-A is required for the repair of DNA breaks induced by replication stress. Mol. Cell. Biol. 29, 5696-5709 (2009).
42. Taylor, S.S., & McKeon, F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89, 727-735 (1997).
43. Soria, G., Polo, S.E., & Almouzni, G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Mol. Cell 46, 722-734 (2012).
44. Lancaster, M.A., & Knoblich, J.A. Spindle orientation in mammalian cerebral cortical development. Curr. Opin. Neurobiol. 22, 737-746 (2012).
45. Lessel, D., et al. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat. Genet. 46, 1239-1244 (2014).
46. Conlon, I., & Raff, M. Size control in animal development. Cell 96, 235-244 (1999).
47. Bicknell, L.S., et al. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat. Genet. 43, 356-359 (2011).
48. Bicknell, L.S., et al. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat. Genet. 43, 350-355 (2011).
49. Guernsey, D.L., et al. Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome. Nat. Genet. 43, 360-364 (2011).
50. Murga, M., et al. A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging. Nat. Genet. 41, 891-898 (2009).
51. Cooke, M.S., Evans, M.D., Dizdaroglu, M., & Lunec, J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17, 1195-1214 (2003).
52. Langevin, F., Crossan, G.P., Rosado, I.V., Arends, M.J., & Patel, K.J. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 475, 53-58 (2011).
53. Frank, K.M., et al. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 5, 993-1002 (2000).
54. Martin, C.A., et al. Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy. Nat. Genet. 46, 1283-1292 (2014).
55. Keupp, K., et al. Mutations in WNT1 cause different forms of bone fragility. Am. J. Hum. Genet. 92, 565-574 (2013).
56. Purcell, S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
57. Joshi, P.K., et al. Directional dominance on stature and cognition in diverse human populations. Nature 523, 459-462 (2015).
58. McQuillan, R., et al. Runs of homozygosity in European populations. Am. J. Hum. Genet. 83, 359-372 (2008).
59. Polo, S.E., et al. Regulation of DNA-End resection by hnRNPU-like proteins promotes DNA double-strand break signaling and repair. Mol. Cell 45, 505-516 (2012).
60. Despras, E., Delrieu, N., Garandeau, C., Ahmed-Seghir, S., & Kannouche, P.L. Regulation of the specialized DNA polymerase eta: revisiting the biological relevance of its PCNA-and ubiquitin-binding motifs. Environ. Mol. Mutagen. 53, 752-765 (2012).
61. Stewart, G.S., Wang, B., Bignell, C.R., Taylor, A.M., & Elledge, S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421, 961-966 (2003).